Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries
The Journal of Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1016/j.jtcvs.2024.04.012 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von J Hunter Mehaffey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa. Electronic address: James.Mehaffey@wvumedicine.org. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Medicare, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, NHLBI.
Abstract (Originalsprache)
OBJECTIVE: Recent approval of transcatheter aortic valve replacement (TAVR) in patients at low surgical risk has resulted in a rapid real-world expansion of TAVR in patients not otherwise examined in recent low-risk trials. We sought to evaluate the outcomes of surgical aortic valve replacement (SAVR) versus TAVR in low-risk Medicare beneficiaries. METHODS: Using the US Centers for Medicare and Medicaid Services claims database, we evaluated all beneficiaries undergoing isolated SAVR (n = 33,210) or TAVR (n = 77,885) (2018-2020). International Classification of Diseases 10th revision codes were used to define variables and frailty was defined by the validated Kim index. Doubly robust risk adjustment was performed with inverse probability weighting and multilevel regression models, as well as competing-risk time to event analysis. A low-risk cohort was identified to simulate recent low-risk trials. RESULTS: A total of 15,749 low-risk patients (8144 SAVR and 7605 TAVR) were identified. Comparison was performed with doubly robust risk adjustment accounting for all factors. TAVR was associated with lower perioperative stroke (odds ratio, 0.62; P < .001) and hospital mortality (odds ratio, 0.16; P < .001) compared with SAVR. However, risk-adjusted longitudinal analysis demonstrated TAVR was associated with higher late risk of stroke (hazard ratio, 1.65; P < .001), readmission for valve reintervention (hazard ratio, 1.88; P < .001), and all-cause mortality (hazard ratio, 1.54; P < .001) compared with SAVR. CONCLUSIONS: Among low-risk Medicare beneficiaries younger than age 75 years undergoing isolated AVR, SAVR was associated with higher index morbidity and mortality but improved 3-year risk-adjusted stroke, valve reintervention, and survival compared with TAVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa. Electronic address: James.Mehaffey@wvumedicine.org.
- Department of Cardiology, West Virginia University, Morgantown, WVa.
- Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- NHLBI
Zitieren
APA
Mehaffey, J. H., Kawsara, M., Jagadeesan, V., Hayanga, J. W. A., Chauhan, D., Wei, L., Mascio, C., Rankin, J. S., Daggubati, R., & Badhwar, V. (2025). Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.04.012
Vancouver
Mehaffey JH, Kawsara M, Jagadeesan V, Hayanga JWA, Chauhan D, Wei L, et al. Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.04.012
BibTeX
@article{Mehaffey2025,
author = {Mehaffey, J Hunter and Kawsara, Mohammad and Jagadeesan, Vikrant and Hayanga, J W Awori and Chauhan, Dhaval and Wei, Lawrence and Mascio, Christopher and Rankin, J Scott and Daggubati, Ramesh and Badhwar, Vinay},
title = {Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1016/j.jtcvs.2024.04.012}
}
EUVIMED